Is RTX a Safe Dividend Stock to Buy?
Summary
Parkev argues that Raytheon is currently benefiting from an unprecedented level of international orders, which have more than doubled year-over-year as global conflicts in the Middle East and Ukraine deplete existing munition supplies. This surge has led the company to revise its annual revenue estimates upward toward $100 billion and prioritize investments in manufacturing capacity to manage its massive $250 billion backlog. Parkev highlights that governments are actively pressuring the company to accelerate production timelines to meet urgent defense needs.
However, Parkev points out significant structural headwinds, specifically the typically low operating profit margins inherent in government defense contracts. With a recent operating margin of just 10.68% and a return on invested capital of 7.6%, the company's profitability is constrained. Parkev also notes that the stock's forward price-to-earnings ratio of 27 is near historical highs, which might suggest the stock is becoming expensive on a relative basis.
Mentioned Stocks
Reasoning: Parkev recommends the stock because his updated discounted cash flow (DCF) model yields a fair value estimate of $232, which is significantly higher than the current market price of $210. He notes that the company has a record backlog of $250 billion and has raised its full-year revenue guidance to nearly $100 billion due to surging demand for munitions. However, he maintains a low conviction level because the company's operating margins (10.68%) and returns on invested capital (7.6%) are relatively low, and the forward P/E of 27 is near historical highs.